SCHEMBL6167358

SCHEMBL6167358

CCCc1nn(-c2ccccn2)c2c1C(=O)CC(C)(C)C2

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.57
NPSR1 Q6W5P4 2/20 0.57
KMT2A Q03164 2/20 0.57
LMNA P02545 1/20 0.54
ALPL P05186 2/20 0.53
OPRM1 P35372 6/20 0.48
GAA P10253 1/20 0.48
CCNA2 P20248 6/20 0.47
CDK2 P24941 6/20 0.47
CCNO P22674 1/20 0.47
CCNE1 P24864 1/20 0.47
CCNA1 P78396 1/20 0.47
HSP90AB1 P08238 1/20 0.44
MAPT P10636 1/20 0.40
THRB P10828 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6164703 0.85 OPRM1 (0.45) ALDH1A1NPSR1KMT2ALMNAOPRM1
SCHEMBL6163724 0.83 ALDH1A1 (0.65) ALDH1A1NPSR1KMT2ALMNAALPL
SCHEMBL6162861 0.82 OPRM1 (0.65) ALDH1A1OPRM1CCNA2CDK2CCNO
SCHEMBL6165407 0.81 ALDH1A1 (0.46) ALDH1A1NPSR1KMT2ALMNAGAA
SCHEMBL6166206 0.80 OPRM1 (0.42) ALDH1A1NPSR1KMT2ALMNAOPRM1
SCHEMBL6165013 0.80 CCNA2 (0.46) ALDH1A1NPSR1KMT2ACCNA2CDK2
SCHEMBL6164595 0.79 CCNA2 (0.47) ALDH1A1KMT2AOPRM1CCNA2CDK2
SCHEMBL6167069 0.79 CCNA2 (0.47) ALDH1A1KMT2AOPRM1CCNA2CDK2
SCHEMBL6165095 0.79 ALDH1A1 (0.58) ALDH1A1NPSR1KMT2ALMNAALPL
SCHEMBL6162155 0.78 OPRM1 (0.57) ALDH1A1KMT2AOPRM1CCNA2CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed
EP-1177185-A1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.p.A. (IT) 2002-02-06 EP disclosed
WO-2000069846-A1 4,5,6,7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.P.A. (IT) 2000-11-23 WO disclosed